User Experiences of the Cue2walk Smart Cueing Device for Freezing of Gait in People with Parkinson’s Disease
Open Access
Abstract
Freezing of gait (FoG) impairs mobility and daily functioning and increases the risk of falls, leading to a reduced quality of life (QoL) in people with Parkinson’s disease (PD). The Cue2walk, a wearable smart cueing device, can detect FoG and hereupon provides rhythmic cues to help people with PD manage FoG in daily life. This study investigated the user experiences and device usage of the Cue2walk, and its impact on health-related QoL, FoG and daily activities. Twenty-five users of the Cue2walk were invited to fill out an online survey, which included a modified version of the EQ-5D-5L, tailored to the use of the Cue2walk, and its scale for health-related QoL, three FoG-related questions, and a question about customer satisfaction. Sixteen users of the Cue2walk completed the survey. Average device usage per day was 9 h (SD 4). Health-related QoL significantly increased from 5.2/10 (SD 1.3) to 6.2/10 (SD 1.3) (p = 0.005), with a large effect size (Cohen’s d = 0.83). A total of 13/16 respondents reported a positive effect on FoG duration, 12/16 on falls, and 10/16 on daily activities and self-confidence. Customer satisfaction was 7.8/10 (SD 1.7). This pilot study showed that Cue2walk usage per day is high and that 15/16 respondents experienced a variety of positive effects since using the device. To validate these findings, future studies should include a larger sample size and a more extensive set of questionnaires and physical measurements monitored over time.Keywords
Funding Information
- ZonMw (10310012210002)
This publication has 34 references indexed in Scilit:
- On‐Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled TrialMovement Disorders, 2024
- Good vibrations: tactile cueing for freezing of gait in Parkinson’s diseaseJournal of Neurology, 2023
- Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysisJournal of Neurology, 2021
- The New Freezing of Gait Questionnaire: Unsuitable as an Outcome in Clinical Trials?Movement Disorders Clinical Practice, 2020
- Compensation Strategies for Gait Impairments in Parkinson DiseaseJAMA Neurology, 2019
- Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitationQuality of Life Research, 2015
- Nonpharmacological treatments for patients with Parkinson's diseaseMovement Disorders, 2015
- The major impact of freezing of gait on quality of life in Parkinson’s diseaseJournal of Neurology, 2014
- Clinical and physiological assessments for elucidating falls risk in Parkinson's diseaseMovement Disorders, 2009
- Freezing phenomenon in patients with parkinsonian syndromesMovement Disorders, 1997